Concepedia

Xiaolin Fan

XF

Statistics

Publications

22

Citations

2K

H-Index

17

Active since

2009

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Jena University Hospital

University of Turin

Novartis (United States)

South Australia Pathology

Xiaolin Fan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and chronic myeloid leukemia therapy.

ORCID

Publications per year

2009–2024

22

Publications

22

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

Neal D. Shore, Fred Saad, Michael S. Cookson et al. · New England Journal of Medicine · 2020 · 436 citations · Full text

, , +17

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Primo N. Lara, Jean‐Yves Douillard, Kazuhiko Nakagawa et al. · Journal of Clinical Oncology · 2011 · 320 citations · Full text

, , +16

Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib

Timothy P. Hughes, Giuseppe Saglio, Hagop M. Kantarjian et al. · Blood · 2013 · 254 citations

, , +7

Rising Incidence of Inflammatory Bowel Disease Among Children: A 12‐year Study

Hoda M. Malaty, Xiaolin Fan, Antone R. Opekun et al. · Journal of Pediatric Gastroenterology and Nutrition · 2009 · 221 citations

, , +16

Fluorene-9-bisphenol is anti-oestrogenic and may cause adverse pregnancy outcomes in mice

Zhaobin Zhang, Ying Hu, Jilong Guo et al. · Nature Communications · 2017 · 127 citations · Full text

, , +14

1–5 of 22